newsAzathioprinefibrotic interstitial lung disease
Evaluating Mycophenolate and Azathioprine in Fibrotic Interstitial Lung Disease: Insights from a Multicenter Retrospective Study
By MedXY|Oct 5, 2026
This study reveals mycophenolate and azathioprine do not improve 3-year transplant-free survival or lung function in fibrotic ILD, with potential harm in select subtypes. Robust randomized trials remain essential for guiding immunosuppressi